Cystic Fibrosis

Cystic fibrosis (CF) is a genetic disorder that affects the lungs and digestive system, caused by mutations in the CFTR gene. In 2025, nearly 105,000 people worldwide live with CF. Advances in treatment, including CFTR modulators, have significantly improved life expectancy and quality of life. Newborn screening guidelines now recommend broader genetic testing to ensure early and accurate diagnosis across diverse populations 

Despite progress, challenges remain, including access to therapies and the need for continued research.  Cystic Fibrosis Australia emphasizes the importance of preserving scientific infrastructure to support innovation and accelerate the development of life-changing treatments.